Figure 2.
Figure 2. Current cooperative group phase III studies of gemtuzumab ozogamicin (GO) in acute myeloid leukemia (AML).

Current cooperative group phase III studies of gemtuzumab ozogamicin (GO) in acute myeloid leukemia (AML).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal